Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

39 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Artificial Intelligence in Chest Radiography Reporting Accuracy: Added Clinical Value in the Emergency Unit Setting Without 24/7 Radiology Coverage.
Rudolph J, Huemmer C, Ghesu FC, Mansoor A, Preuhs A, Fieselmann A, Fink N, Dinkel J, Koliogiannis V, Schwarze V, Goller S, Fischer M, Jörgens M, Ben Khaled N, Vishwanath RS, Balachandran A, Ingrisch M, Ricke J, Sabel BO, Rueckel J. Rudolph J, et al. Among authors: ben khaled n. Invest Radiol. 2022 Feb 1;57(2):90-98. doi: 10.1097/RLI.0000000000000813. Invest Radiol. 2022. PMID: 34352804
p70 Ribosomal Protein S6 Kinase Is a Checkpoint of Human Hepatic Stellate Cell Activation and Liver Fibrosis in Mice.
Reiter FP, Ye L, Ofner A, Schiergens TS, Ziesch A, Brandl L, Ben Khaled N, Hohenester S, Wimmer R, Artmann R, He Y, Lee SML, Mayr D, Zhang C, Gerbes AL, Mayerle J, Denk G, De Toni EN. Reiter FP, et al. Among authors: ben khaled n. Cell Mol Gastroenterol Hepatol. 2022;13(1):95-112. doi: 10.1016/j.jcmgh.2021.09.001. Epub 2021 Sep 17. Cell Mol Gastroenterol Hepatol. 2022. PMID: 34537439 Free PMC article.
Current State of Multidisciplinary Treatment in Cholangiocarcinoma.
Ben Khaled N, Jacob S, Rössler D, Bösch F, De Toni EN, Werner J, Ricke J, Mayerle J, Seidensticker M, Schulz C, Fabritius MP. Ben Khaled N, et al. Dig Dis. 2022;40(5):581-595. doi: 10.1159/000520346. Epub 2021 Oct 25. Dig Dis. 2022. PMID: 34695826 Review.
Atezolizumab and bevacizumab with transarterial chemoembolization in hepatocellular carcinoma: the DEMAND trial protocol.
Ben Khaled N, Seidensticker M, Ricke J, Mayerle J, Oehrle B, Rössler D, Teupser D, Ehmer U, Bitzer M, Waldschmidt D, Fuchs M, Reuken PA, Lange CM, Wege H, Kandulski A, Dechêne A, Venerito M, Berres ML, Luedde T, Kubisch I, Reiter FP, De Toni EN. Ben Khaled N, et al. Future Oncol. 2022 Apr;18(12):1423-1435. doi: 10.2217/fon-2021-1261. Epub 2022 Jan 27. Future Oncol. 2022. PMID: 35081747
Reply.
Ben Khaled N, Rössler D, Reiter FP, Mayerle J, Lange CM, Seidensticker M, Guba M, De Toni EN. Ben Khaled N, et al. Liver Transpl. 2022 May;28(5):897-898. doi: 10.1002/lt.26410. Epub 2022 Mar 10. Liver Transpl. 2022. PMID: 35090084 No abstract available.
Ipilimumab and nivolumab in advanced hepatocellular carcinoma after failure of prior immune checkpoint inhibitor-based combination therapies: a multicenter retrospective study.
Roessler D, Öcal O, Philipp AB, Markwardt D, Munker S, Mayerle J, Jochheim LS, Hammer K, Lange CM, Geier A, Seidensticker M, Reiter FP, De Toni EN, Ben Khaled N. Roessler D, et al. Among authors: ben khaled n. J Cancer Res Clin Oncol. 2023 Jul;149(7):3065-3073. doi: 10.1007/s00432-022-04206-8. Epub 2022 Jul 21. J Cancer Res Clin Oncol. 2023. PMID: 35864269 Free PMC article.
39 results